Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
NCT04101838Phase 4Active, not recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2021
- Primary completion
- May 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent, influenza virus vaccine, split virion in influenza, sponsored by University of Alabama at Birmingham. Started Apr 2021; status: active, not recruiting.
02
Drugs
Fluzone Trivalentinfluenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04101838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101838.